Back to companies

Cytokinetics Inc: Premium Databases

Cytokinetics Inc Catalyst Calendar

Proactively evaluate Cytokinetics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

A sample of Cytokinetics Inc Catalyst Calendar data

Event Date Event Type Company Name Ticker Symbol Drug Name Therapy Area Indication Source Type
Showing 3 of 40+ results. Subscribe to unlock more.
30 Jun 2020 GDCTXXXX Lorem Lorem Lorem XXXX Planned Lorem
31 Mar 2020 Phase III Trial Results Cytokinetics Inc; GenesisCare Clinical CRO Pty Ltd; Jinsheng Biotechnology Consulting (Shanghai) Co Ltd; Patheon NV CYTK omecamtiv mecarbil MR Cardiovascular Chronic Heart Failure; Congestive Heart Failure (Heart Failure); Systolic Heart Failure Company Press Release
04 Mar 2020 Phase I Trial Completion Cytokinetics Inc CYTK omecamtiv mecarbil MR Cardiovascular Systolic Heart Failure Clinical Trial Registry
01 Dec 2019 Phase II Trial Initiation Cytokinetics Inc CYTK aficamten Cardiovascular Hypertrophic Cardiomyopathy Clinical Trial Registry
Catalyst Calendar


Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.



  • Trial Events for trials conducted globally by a company, university, institute or CRO:  Trial Initiation, Trial Completion, Trial Results
  • Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
  • Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)


Proactively evaluate companies and catalyst impacts

Stay ahead of the competition & improve corporate planning

Bolster business development with timely opportunities

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.


Access more premium companies when you subscribe to Explorer